Welcome to the Center for Neurodegeneration and Experimental Therapeutics
The Center for Neurodegeneration and Experimental Therapeutics (CNET) is devoted to finding therapies for neurodegenerative diseases, including Alzheimer’s disease and related dementias, Parkinson’s disease, Huntington’s disease, and ALS. CNET’s core goals are to promote the discovery of novel treatments for neurodegenerative disorders through basic and translational research, to teach scientists and clinicians about these diseases, and to facilitate the application of these discoveries to clinical care of patients.
We are pleased to announce a new NINDS T32, “UAB Training Program in Neurodegeneration.” This is a 2 year program for predoctoral students in basic and translational approaches to neurodegenerative disease. We anticipate funding 2 positions for the 2017-18 academic year. Students will be entering their third or fourth year of graduate training at the time of appointment. Click here for more details!
